NIH-funded research R01 grant

Ways to boost HIV prevention uptake for adults at drinking venues in East Africa

Official title: Innovative strategies to promote biomedical HIV prevention uptake and retention among high-risk adults at drinking venues in Kenya and Uganda

Funded at University of California, San Francisco · NIH-11553387 · Data updated 2026-11-12

A study exploring a new approach to help adults at risk for HIV in Kenya and Uganda start and keep using HIV prevention tools like PrEP and PEP, by engaging them in drinking venues.

More HIV Prevention research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of California, San Francisco
NIH-funded
Lab location1 site (San Francisco, United States)
Project startSeptember 1, 2022
Project endJune 30, 2027
Funding year2026
Award (this year)$53,417
NIH project number3R01AA030464-05S2
Project IDNIH-11553387 on NIH RePORTER

Who could benefit from this research

Could help

Adults in Kenya and Uganda who frequent drinking venues and are at high risk for HIV, including those with heavy alcohol use.

Less likely to help

Individuals not at risk or not engaging with HIV prevention services may not benefit from this specific approach.

What this research studies

This project tests a strategy that brings HIV testing and prevention services to alcohol-serving venues in Kenya and Uganda to reach people at high risk. It builds on a multi-disease screening approach to recruit and connect more than 2,000 adults to biomedical HIV prevention options. The aim is to increase acceptance and ongoing use of PrEP/PEP and reduce barriers such as stigma and misperceived risk. Researchers will work with community venues and local partners to implement and refine the intervention in real-world settings. If successful, the approach could broaden access to HIV prevention for people who are hardest to reach in sub-Saharan Africa.

Why it matters

Potential benefit: If successful, the strategy could improve uptake and retention in HIV prevention services, potentially reducing new HIV infections in high-risk populations.

How similar studies have gone: Previous work shows that venue-based outreach can engage at-risk populations, with potential for improved prevention uptake in similar settings.

Where this research is happening

  • University of California, San Francisco
    San Francisco, United States
    Active

Researchers

  • Principal investigator: Chamie, Gabriel — University of California, San Francisco
  • Study coordinator: Chamie, Gabriel

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.